Faron Pharmaceuticals Oy (FPHAF) Q4 2025 Earnings Call Transcript [Seeking Alpha]
ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
proqr.com
Company Research
Source: Seeking Alpha
Juho Jalkanen - Founder, CEO & Director Jurriaan Dekkers - Chief Financial Officer Presentation Juho Jalkanen Founder, CEO & Director Hello, everyone. Welcome to the Faron Pharmaceuticals Annual Results Webcast for 2025. My name is Juho Jalkanen, the CEO of the company. Here with me today are new CFO, Jurriaan. Jurriaan Dekkers Chief Financial Officer Hi. So my name is Jurriaan Dekkers. I started as CFO on the 1st of December 2025, replacing Yrjo, who decided to retire by the end of March this year. I've been working in different global, regional and local finance roles over the last 25 years with a focus on health care and biotech. My last role was at ProQR Therapeutics, CFO of a Dutch-based Nasdaq-listed company. Before that, I've been working at AstraZeneca, CFO in the Netherlands, but also for Acerta and DaVita Medical Group. Together with my wife, I have two daughters, and I enjoy sailing a lot. Juho Jalkanen Founder, CEO & Director Thank you, Jurriaan. All
Show less
Read more
Impact Snapshot
Event Time:
PRQR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRQR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRQR alerts
High impacting ProQR Therapeutics N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRQR
News
- ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference [Yahoo! Finance]Yahoo! Finance
- ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences ConferenceGlobeNewswire
- ProQR Announces Planned Changes to Board CompositionGlobeNewswire
- ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 OutlookGlobeNewswire
- ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are individual investors with 34% stake, while 29% is held by institutions [Yahoo! Finance]Yahoo! Finance
PRQR
Earnings
- 11/6/25 - In-Line
PRQR
Sec Filings
- 2/9/26 - Form 6-K
- 2/6/26 - Form SCHEDULE
- 1/20/26 - Form SCHEDULE
- PRQR's page on the SEC website